NPPA issued a notification regarding the fixation of the retail price of Empagliflozin 12.5 mg + Metformin Hydrochloride IP 500 mg for M/s Lifecare Formulations Pvt. Ltd. (Manufacturer) and M/s Primus Remedies Pvt. Ltd. (Marketer)

Mar 04, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 03, 2025, issued a notification regarding the fixation of the retail price of Empagliflozin 12.5 mg + Metformin Hydrochloride IP 500 mg for M/s Lifecare Formulations Pvt. Ltd. (Manufacturer) and M/s Primus Remedies Pvt. Ltd. (Marketer).

The following has been stated: -

•For Each Film Coated Tablet Contains: Empagliflozin 12.5 mg + Metformin Hydrochloride IP 500 mg for M/s Lifecare Formulations Pvt. Ltd. (Manufacturer) and M/s Primus Remedies Pvt. Ltd. (Marketer) the retail price is 36.19 (Rs)


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT